ABSTRACT To determine whether asthma alone can cause irreversible airflow obstruction 42 men and 47 women with chronic asthma (mean duration 22 (SD 13) years) without evidence of other disease likely to cause irreversible airflow obstruction were treated with theophylline orally and a beta agonist both orally and by inhalation for four weeks. After two weeks of treatment the FEV, was less than 85% of the predicted normal value (%P) in 48 patients and these individuals then received prednisolone 0*6 mg/kg/day for two weeks. Duration and severity of asthma and smoking history were quantified by questionnaire; 38 patients were current smokers or ex-smokers. FEV1 was measured at 0, 2, and 4 weeks. The mean difference between the best FEV1 during the study and the predicted normal value was 0-29 1 (p < 0.001); FEVy %P decreased with age (r = -030, p < 0.01) and with the duration (r = -0 47, p < 0.001) and severity (r = -0*55, p < 0.001) of asthma. Similar findings were noted when the results for non-smokers and those whose asthma started in adult life were analysed separately. We conclude that asthma alone can cause irreversible airflow obstruction and that the degree of obstruction is a function of the duration and severity of previous asthma. The results suggest the possibility that irreversible airflow obstruction in asthma may be preventable by minimising the degree of persistent asthma.
Evidence from several studies suggests that chronic asthma may be associated with the development of irreversible airflow obstruction. Firstly, pulmonary function is frequently abnormal during clinical remission from asthma;'-' secondly, the airways of patients with chronic asthma dying from nonrespiratory causes show changes including mucous plugging, chronic inflammatory and eosinophilic infiltration, basement membrane thickening, and smooth muscle hypertrophy,89 which could cause persistent narrowing; and, thirdly, many patients with asthma by definition have persistent airflow obstruction, which is not reversed by intensive treatment including corticosteroids.'0" Despite this evidence, a relationship between asthma and irreversible airflow obstruction has not been finnly established because there has been no large scale study of ventilatory function in patients with asthma in which reversible obstruction has been minimised by intensive treatment and in which other conditions likely to cause irreversible obstruction, such as emphysema, cigarette smoking, and occupational airway disease, have been either considered or excluded. This paper reports such a study, the aims of which were to determine whether asthma alone can cause irreversible airflow obstruction and whether factors such as cigarette smoking, age of onset of asthma, and duration and severity of previous asthma were associated with any irreversible obstruction.
Patients and methods
One hundred patients with asthma of more than three years' duration who were attending outpatient clinics of the department of respiratory medicine at the Sir Charles Gairdner Hospital were studied. The patients had a clinical diagnosis of asthma with variability in the FEVI of at least 20% within a period of six months before the study; 70% showed marked variation of FEVI with changes of over 50% in this period. The 
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Burrows et all' and based on age, sex, height, and cigarette smoking. Use of these data to predict the FEV, of an Australian population, however, could be inappropriate. We therefore also compared the highest FEVI of asthmatic subjects who had never smoked with that predicted from FEV, data obtained during the 1972 Busselton (W Australia) population survey on 514 men and 1024 women over 18 years of age who had never smoked and had no history of lung or heart disease'6 (also N Stenhouse, personal communication); data on symptom free Australian smokers were not available for comparison. The relationships between FEV, and age, age at onset and duration of asthma, the score for severity of asthma, cigarette consumption, and chronic cough and sputum were examined by linear regression and multiple regression analyses. Differences in these relationships between subgroups were examined by comparison of regression lines.'" Results Eighty nine of the 100 patients completed the study; 10 did not attend for review appointments and one patient withdrew because of tremor induced by salbutamol. Tremor caused 22 patients to discontinue oral salbutamol; in 12 of them terbutaline, 5 mg three times a day, was successfully substituted. Ten patients discontinued theophylline because of gastrointestinal side effects. All patients treated with prednisolone completed two weeks of treatment; no adverse effects were noted. Table 1 summarises the principal characteristics of the 89 patients who completed the study. tIncludes number of current smokers (C) and ex-smokers (E). 4 :Number with cough and sputum who had never smoked in square brackets.
NS-not significant. survey'6 were used to predict FEV, ( There were no significant correlations between age and duration or age and severity of asthma, between duration and self-assessment of asthma severity or between FEV %P and age of onset of asthma, or between FEV, 4oP and smoking history, either for all subjects or men and women separately. The mean severity score was significantly higher (p < 0.01) in women (317 + 148) than in men (235 (SD 144)). FEV, %P was significantly correlated (p < 0-01 or < 0-001) with the score for impairment of daily activities (r = -0-33), hospital admissions (r = -0.31), the patients' self-assessment of asthma severity (r = -0.29), usual medication requirements (r = -0-42), and duration and severity of wheeze (r = -0-43). Total severity score and the patients' self-assessment of the severity of asthma were highly correlated (r = 0-56, p < 0-001).
Discussion
The results of this study suggest that asthma alone can cause irreversible airflow obstruction and that Significance of differences and correlations: tp < 0-05; t p < 0*01; §p<O*OOl. Methods of estimating the severity of previous asthma are necessarily imprecise because they depend largely on subjective criteria and on the weighting applied to these criteria by the investigators. Nevertheless, in this study the factors used to quantitate severity, except for loss of time from work, bore a consistent relationship to the highest FEVI during treatment and were internally consistent with the patients' assessment of the severity of their asthma.
Some support for the suggestion that asthma alone can cause irreversible airflow obstruction comes from previous studies of airway function during remission from asthma even though these were not designed to examine this question. 4 Loren et al reported three children with severe asthma and an irreversible component of airflow obstruction despite intensive treatment with bronchodilators and prednisolone.'0 Factors which may contribute to the development of irreversible airflow obstruction include cigarette smoking and respiratory illness in childhood. 26 Our results in lifelong non-smokers and in those whose asthma started after the age of 15 years showed that the development of irreversible obstruction in asthma is not dependent on smoking or on a childhood onset of asthma. Furthermore, neither these factors nor chronic cough and sputum appear to influence the degree of airflow obstruction.
The observation that the women in this study had a significantly greater decline of FEV, with age than men, but no difference in the severity of asthma as a function of age or duration of disease, suggests a possible sex related difference in the degree of irreversible obstruction that is independent of the severity of asthma. The strong relationship between the degree of airflow obstruction and the duration and severity of asthma, which together accounted for 37% of the variability in FEV, %P, suggests that chronic poorly controlled asthma causes irreversible narrowing of airways and raises the possibility that improved control of asthma may prevent irreversible obstruction. The findings therefore provide some support for recent suggestions that one of the aims of treatment in chronic asthma should be to maintain airway function as near normal as practicable. 27 The extent to which the conclusions of our study apply to the general population of patients with asthma cannot be stated. There is, however, a high incidence of airflow obstruction in non-hospital patients with asthma ;6 28 if persistent asthma can cause irreversible obstruction then the implications are general.
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